Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
With a market cap of 153.37B, Pfizer(PFE) trades at $26.98. The stock has a price-to-earnings ratio of 19.48 and currently yields dividends of 6.5%.
During the trading session on 2026-02-06, Pfizer(PFE) shares reached a daily high of $27.05 and a low of $26.40. At a current price of $26.98, the stock is +2.2% higher than the low and still -0.3% under the high.
Trading volume for Pfizer(PFE) stock has reached 5.83M, versus its average volume of 60.31M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.
PFE News
Pfizer (PFE) announced on Friday that the U.S. Food and Drug Administration granted priority review for a marketing application seeking a label expansion for it...
Pfizer (PFE) announced that the U.S. FDA has accepted and granted Priority Review for the company’s supplemental Biologics License Application for Hympavzi to e...
(RTTNews) - Pfizer Inc. (PFE) announced the launch of its TrumpRx program, designed to make innovative medicines more affordable and accessible to millions of A...
Analyst ratings
57%
of 28 ratingsMore PFE News
Pfizer (PFE) said it “announced the launch of its program on TrumpRx, making innovative medicines more affordable and accessible to millions of Americans. Start...
President Donald Trump in September announced a drug-pricing deal with Pfizer. The Trump administration has since struck deals with 15 other pharmaceutical comp...
AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...
Investors in Pfizer Inc (Symbol: PFE) saw new options become available today, for the March 27th expiration. At Stock Options Channel , our YieldBoost formula h...
Eli Lilly and Novo Nordisk may want to enjoy their duopoly while they can. Eli Lilly's (LLY +10.33%) obesity drug, Zepbound, generated sales of $13.5 billion i...
Pfizer (NYSE:PFE) reported statistically significant weight loss results from its Phase 2b VESPER-3 trial for a monthly injectable GLP-1 obesity drug. The cand...
Key Points Eli Lilly has leading products in the GLP-1 space, with plans to bring pill versions of its weight loss shots to market. Pfizer is playing catch-up...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.